A strong franchise. A clean balance sheet.

A proven track record. But what if the growth engine is starting to slow? The chemistry is strong. The business is known. But the earnings momentum has not shown the same tone. PI Industries built its reputation through agrochemicals, contract research and manufacturing, serving global innovators with complex molecules and technical capabilities. That was the old strength. Now comes the new challenge: THE GROWTH EQUATION IS CHANGING Global agrochemical markets have faced inventory correction, pricing pressure and weak demand. And PI isn't immune. In Q4 FY26, net profit fell 39% YoY to ₹200 crore, triggering a sharp market reaction. The stock fell more than 7% following the results as investors questioned the pace of recovery. So the equation becomes: Revenue pressure → Lower operating leverage → Margin pressure → Slower earnings growth And when earnings slow, valuation matters more. That's the biggest bearish argument. PI has historically enjoyed a premium because investors valued its asset-light model, strong return ratios, cash generation and long-term growth potential. But a premium business needs premium growth. If growth normalises, the premium can normalise too. Then there is the agrochemical cycle. Crop prices fluctuate. Farmer economics fluctuate. Inventory cycles fluctuate. Global demand fluctuates. And when customers carry excess inventory: Orders get delayed. Volumes get pushed out. Factories run below potential. PI is also investing heavily in its new-age businesses and life-sciences platform, which could create a large opportunity — but new businesses require time, capital and execution before they contribute meaningfully to earnings.